Spectrumedics is a pioneering medical device start-up that is revolutionizing the field by introducing disruptive technologies to address unmet clinical needs in the treatment of cardiovascular diseases. The company was founded by a dynamic duo of scientist-engineers, boasting over 10 years of industrial experience in the development and manufacturing of minimally invasive cardiovascular devices. With a strong commitment to innovation, Spectrumedics is at the forefront of integrating energy-based technologies with interventional techniques. Leveraging on our platform technology, we have successfully overcome various challenges associated with cardiovascular calcification, opening up a wide range of clinical applications. The initial focus of our groundbreaking Sonico Intravascular Lithotripsy System will be on treating stenotic calcified lesions in both coronary and peripheral arteries, marking significant advancements in the field.